Necitumumab | Interleukin Related interleukin-related.com

Product Name :
Necitumumab

Search keywords :
Necitumumab

drugId :
null

Target Vo:
Epidermal growth factor receptor erbB1

Target Vo Short Name :
EGFR

Moa_Name:
Epidermal growth factor receptor erbB1 antagonists

First Approval Country :
United States

First Approval Date Filter:
2015

Origin Company_Name :
Eli Lilly And Company

Active Company_Name :
Eli Lilly And Co (Ireland) Ltd

Active Indication_Name:
Carcinoma, Non-Small-Cell Lung

In Active Indication_Name:
Colorectal Neoplasms

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Cleaved-Caspase 3 p12 Antibody
Glucose Transporter GLUT4 Antibody
NFAT2 Antibody: NFAT2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 101 kDa, targeting to NFAT2. It can be used for WB,ICC,IHC-P,FC assays with tag free, in the background of Human.

Author: Interleukin Related

Related Posts